OYC Americas

Executive Summary

OYC Americas is a private company based in Cambridge, US, that supplies high-quality raw materials derived from yeast fermentation for life science research, clinical diagnostics, pharmaceuticals, and human nutrition. Founded in 2017 and currently at the pre-clinical stage, the company serves as a critical enabler of healthcare innovation by providing essential components such as recombinant proteins, enzymes, and other biomolecules. Its fermentation expertise and focus on quality allow it to address the growing demand for reliable, scalable raw materials in the biopharma and diagnostics sectors. With the increasing adoption of biologics and personalized medicine, OYC Americas is well-positioned to capture market share as a trusted partner for both established pharmaceutical companies and emerging biotechs. The company's strategic location in Cambridge, a major biotech hub, further enhances its ability to collaborate and expand its customer base. While financial details such as total raised and valuation are not disclosed, the company's focus on a high-demand niche suggests a solid growth trajectory.

Upcoming Catalysts (preview)

• Q3 2026New Supply Agreement with Major Pharma70% success
• Q4 2026Expansion into Diagnostic Enzyme Market60% success
• Q2 2026ISO 13485 Certification for Quality Management80% success